...
首页> 外文期刊>Medical care >Do HMO market level factors lead to racial/ethnic disparities in colorectal cancer screening? A comparison between high-risk Asian and Pacific Islander Americans and high-risk whites.
【24h】

Do HMO market level factors lead to racial/ethnic disparities in colorectal cancer screening? A comparison between high-risk Asian and Pacific Islander Americans and high-risk whites.

机译:HMO市场水平因素是否会导致大肠癌筛查的种族/种族差异?高风险的亚裔和太平洋岛民与高风险的白人之间的比较。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Few studies have explored health care market structure and colorectal cancer (CRC) screening test use, and little is known whether market factors contribute to racial/ethnic screening disparities. OBJECTIVE: We investigated whether HMO market level factors, controlling for individual covariates, differentially impact Asian American and Pacific Islander (AAPI) subjects' access to CRC screening compared with white subjects. RESEARCH DESIGN AND METHODS: We used random intercept hierarchical models to predict CRC test use. Individual-level survey data was linked to market data by metropolitan statistical areas from InterStudy. SUBJECTS: Insured first-degree relatives, ages 40-80, of a random sample of colorectal cancer cases identified from the California Cancer Registry: 515 white subjects and 396 AAPI subjects residing in 36 metropolitan statistical areas (MSAs). MEASURES: Dependent variables were receipt of (1) annual fecal occult blood test only; (2) sigmoidoscopy in the past 5 years; (3) colonoscopy in the past 10 years; and (4) any of these tests over the recommended time interval. Market characteristics were HMO penetration, HMO competition, and proportion of staff/groupetwork HMOs. FINDINGS: Market characteristics were as important as individual-level characteristics for AAPI but not for white subjects. Among AAPI subjects, a 10% increase in the percent of group/staffetwork model HMO was associated with a reduction in colonoscopy use (28.9% to 20.5%) and in receipt of any of the CRC tests (53.2% to 45.4%). CONCLUSIONS: The prevailing organizational structure of a health care market confers a penalty on access to CRC test use among high-risk AAPI subjects but not among high-risk white subjects. Identifying the differential effect of market structure on race/ethnicity can potentially reduce the cancer burden among disadvantaged racial groups.
机译:背景:很少有研究探索医疗保健市场结构和结肠直肠癌(CRC)筛查测试的用途,而市场因素是否导致种族/族裔筛查差异是鲜为人知的。目的:我们调查了控制个体协变量的HMO市场水平因素与白人受试者相比是否对亚裔和太平洋岛民(AAPI)受试者进行CRC筛查有不同的影响。研究设计和方法:我们使用随机截距分层模型来预测CRC测试的使用。 InterStudy的大都市统计区域将个人水平的调查数据与市场数据链接了起来。受试者:从加利福尼亚癌症登记处确定的大肠癌病例随机样本,年龄在40-80岁之间的被保险一级亲属:居住在36个都市统计区域(MSA)中的515名白人受试者和396名AAPI受试者。措施:因变量是(1)仅接受年度大便潜血测试; (2)近5年来的乙状结肠镜检查; (3)近10年来的结肠镜检查; (4)在建议的时间间隔内进行任何这些测试。市场特征是HMO渗透率,HMO竞争以及员工/小组/网络HMO的比例。结果:对于AAPI,市场特征与个人特征一样重要,但对于白人受试者则不然。在AAPI受试者中,组/员工/网络模型HMO的百分比增加10%与结肠镜检查的使用减少(28.9%至20.5%)和接受任何CRC测试(53.2%至45.4%)有关。结论:医疗保健市场的现行组织结构赋予高风险AAPI受试者使用CRC测试使用的惩罚,而高风险白人受试者则没有。确定市场结构对种族/民族的不同影响可以潜在地减轻处境不利的种族群体的癌症负担。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号